{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:38:08Z","timestamp":1771983488930,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03608-7","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T10:35:10Z","timestamp":1735554910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-microbial impact of non-antibiotic agents; salicylic acid, N-acetylcysteine, and isotretinoin against Cutibacterium acnes in patients with acne vulgaris"],"prefix":"10.1007","volume":"317","clinical-trial-number":[{"clinical-trial-number":"nct06179056","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Reham","family":"Essam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha W.","family":"Khater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma","family":"Fayez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourhan","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"issue":"4","key":"3608_CR1","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/jocd.13765","volume":"20","author":"C Stamu-O'Brien","year":"2021","unstructured":"Stamu-O\u2019Brien C, Jafferany M, Carniciu S et al (2021) Psychodermatology of acne: psychological aspects and effects of acne vulgaris. J Cosmet Dermatol 20(4):1080\u20131083","journal-title":"J Cosmet Dermatol"},{"key":"3608_CR2","first-page":"52","volume":"20","author":"V Kumar","year":"2021","unstructured":"Kumar V (2021) Going, Toll-like receptors in skin inflammation and inflammatory diseases. EXCLI J 20:52","journal-title":"EXCLI J"},{"issue":"8","key":"3608_CR3","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/antibiotics11081032","volume":"11","author":"MA Swallow","year":"2022","unstructured":"Swallow MA, Fan R, Cohen JM, Bunick CG (2022) Antibiotic resistance risk with oral tetracycline treatment of acne vulgaris. Antibiotics 11(8):1032","journal-title":"Antibiotics"},{"key":"3608_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13555-018-0275-9","volume":"9","author":"DE Castillo","year":"2019","unstructured":"Castillo DE, Nanda S, Keri JE (2019) Propionibacterium (Cutibacterium) acnes bacteriophage therapy in acne: current evidence and future perspectives. Dermatol Therap 9:19\u201331","journal-title":"Dermatol Therap"},{"key":"3608_CR5","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.4049\/jimmunol.180.7.4919","volume":"180","author":"P Liu","year":"2008","unstructured":"Liu P, T, Phan J, Tang D, et al (2008) CD209(+) macrophages mediate host defense against Propionibacterium acnes. J Immunol 180:4919\u20134923","journal-title":"J Immunol"},{"issue":"11","key":"3608_CR6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/14728222.2018.1527314","volume":"22","author":"P Zimmermann","year":"2018","unstructured":"Zimmermann P, Nigel C (2018) The effect of aspirin on antibiotic susceptibility. Expert Opin Ther Targets 22(11):967\u2013972","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"3608_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bjd.12149","volume":"168","author":"K Bhate","year":"2013","unstructured":"Bhate K, Williams HC (2013) Epidemiology of acne vulgaris. Br J Dermatol 168(3):474\u2013485","journal-title":"Br J Dermatol"},{"issue":"11","key":"3608_CR8","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1111\/jocd.15210","volume":"21","author":"W Albalat","year":"2022","unstructured":"Albalat W, Darwish H, Abd-Elaal WH et al (2022) The potential role of insulin-like growth factor 1 in acne vulgaris and its correlation with the clinical response before and after treatment with metformin. J Cosmet Dermatol 21(11):6209\u20136214","journal-title":"J Cosmet Dermatol"},{"key":"3608_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12895-020-00108-9","volume":"20","author":"E Alkhawaja","year":"2020","unstructured":"Alkhawaja E, Hammadi S, Abdelmalek M et al (2020) Antibiotic-resistant Cutibacterium acnes among acne patients in Jordan: a cross-sectional study. BMC Dermatol 20:17","journal-title":"BMC Dermatol"},{"issue":"2","key":"3608_CR10","doi-asserted-by":"publisher","first-page":"e022938","DOI":"10.1136\/bmjopen-2018-022938","volume":"9","author":"T Zhu","year":"2019","unstructured":"Zhu T, Zhu W, Wang Q, He L, Wu W, Liu J, Li Y, Sun D (2019) Antibiotic susceptibility of Propionibacterium acnes\u00a0isolated from patients with acne in a public hospital in Southwest China: a prospective cross-sectional study. BMJ Open 9(2):e022938","journal-title":"BMJ Open"},{"key":"3608_CR11","unstructured":"Clinical and Laboratory Standards Institute. (2012). Methods for antimicrobial susceptibility testing of anaerobic bacteria: 8th edition. CLSI document M11\u2013A8, USA."},{"key":"3608_CR12","unstructured":"Clinical and Laboratory Standards Institute (2004): Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standards. 6th ed. NCCLS M11-A6. Wayne, PA."},{"issue":"4","key":"3608_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.resmic.2007.02.001","volume":"158","author":"T Coenye","year":"2007","unstructured":"Coenye T, Peeters E, Nelis HJ (2007) Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol 158(4):386\u2013392","journal-title":"Res Microbiol"},{"key":"3608_CR14","doi-asserted-by":"publisher","first-page":"102580","DOI":"10.1016\/j.anaerobe.2022.102580","volume":"76","author":"C Abbott","year":"2022","unstructured":"Abbott C, Grout E, Morris T, Brown HL (2022) Cutibacterium acnes biofilm-forming clinical isolates modify the formation and structure of Staphylococcus aureus biofilms, increasing their susceptibility to antibiotics. Anaerobe 76:102580","journal-title":"Anaerobe"},{"issue":"8","key":"3608_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1469-0691.2009.02747.x","volume":"15","author":"A Holmberg","year":"2009","unstructured":"Holmberg A, Lood R, M\u00f6rgelin M, S\u00f6derquist B, Holst E, Collin M, Christensson B, Rasmussen M (2009) Biofilm formation by Propionibacterium acnes is a characteristic of invasive isolates. Clin Microbiol Infect 15(8):787\u2013795","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"3608_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovi\u0107","year":"2007","unstructured":"Stepanovi\u0107 S, Vukovi\u0107 D, Hola V et al (2007) Quantification of biofilm in microtiter plates Overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. Acta Pathol Microbiol Immunol Scand 115(8):891\u2013899","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"issue":"5","key":"3608_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00403-019-01908-x","volume":"311","author":"TX Cong","year":"2019","unstructured":"Cong TX, Hao D, Wen X et al (2019) From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res 311(5):337\u2013349","journal-title":"Arch Dermatol Res"},{"key":"3608_CR18","doi-asserted-by":"publisher","first-page":"e14150","DOI":"10.1111\/dth.14150","volume":"33","author":"M Aslan Kayiran","year":"2020","unstructured":"Aslan Kayiran M, Karadag AS, Jafferany M (2020) Psychodermatology of acne: Dermatologist\u2019s guide to inner side of acne and management approach. Dermatol Ther 33:e14150","journal-title":"Dermatol Ther"},{"issue":"1","key":"3608_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/mdr.2018.0027","volume":"25","author":"V Cepas","year":"2019","unstructured":"Cepas V, L\u00f3pez Y, Mu\u00f1oz E, Rolo D, Ardanuy C, Mart\u00ed S, Xercavins M, Horcajada JP, Bosch J, Soto SM (2019) Relationship between biofilm formation and antimicrobial resistance in gram-negative bacteria. Microb Drug Resist 25(1):72\u201379","journal-title":"Microb Drug Resist"},{"key":"3608_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1099\/jmm.0.067611-0","volume":"63","author":"K Nakase","year":"2014","unstructured":"Nakase K, Nakaminami H, Takenaka Y (2014) the relationship between severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan. J Med Microbiol 63:721\u2013728","journal-title":"J Med Microbiol"},{"issue":"10","key":"3608_CR21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/jof8101049","volume":"8","author":"E Salvatore","year":"2022","unstructured":"Salvatore E (2022) All-trans retinoic acid effect on Candida albicans growth and biofilm formation. J Fungi 8(10):1049","journal-title":"J Fungi"},{"issue":"1","key":"3608_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1067\/mjd.2003.618","volume":"49","author":"H Gollnick","year":"2003","unstructured":"Gollnick H (2003) Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad dermatol 49(1):1\u201337","journal-title":"J Am Acad dermatol"},{"issue":"6","key":"3608_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1365-2133.2005.06897.x","volume":"153","author":"P Coates","year":"2005","unstructured":"Coates P (2005) Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne. Br J Dermatol 153(6):1126\u20131136","journal-title":"Br J Dermatol"},{"issue":"17-18","key":"3608_CR24","doi-asserted-by":"publisher","first-page":"E540","DOI":"10.1503\/cmaj.160139","volume":"188","author":"S Michael","year":"2016","unstructured":"Michael S, Joseph M (2016) Infantile acne. Can Med Assoc J 188(17\u201318):E540\u2013E540","journal-title":"Can Med Assoc J"},{"issue":"1","key":"3608_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/cjm-2023-0123","volume":"70","author":"EME Sykes","year":"2024","unstructured":"Sykes EME, White D, McLaughlin S, Kumar A (2024) Salicylic acids and pathogenic bacteria: new perspectives on an old compound. Can J Microbiol 70(1):1\u201314","journal-title":"Can J Microbiol"},{"key":"3608_CR26","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1128\/AAC.00561-11","volume":"55","author":"J Pannu","year":"2011","unstructured":"Pannu J (2011) In Vitro Antibacterial Activity of NB003 against Propionibacterium acnes. Antimicrob Agents Chemother 55:4211\u20134217","journal-title":"Antimicrob Agents Chemother"},{"key":"3608_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203941","author":"S Pollini","year":"2018","unstructured":"Pollini S, Pilato V, Landini G (2018) In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0203941","journal-title":"PLoS ONE"},{"key":"3608_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.micpath.2017.02.030","volume":"105","author":"D Eroshenko","year":"2017","unstructured":"Eroshenko D, Tatyana P (2017) N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens. Microb Pathog 105:145\u2013152","journal-title":"Microb Pathog"},{"issue":"6","key":"3608_CR29","first-page":"348","volume":"10","author":"LF Montes","year":"2012","unstructured":"Montes LF, Walter H et al (2012) Topical acne treatment with acetylcysteine: clinical and experimental effects. Skin med 10(6):348\u2013435","journal-title":"Skin med"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03608-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03608-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03608-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T11:03:56Z","timestamp":1735556636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03608-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3608"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03608-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Consent for the publication of identifiable material was obtained by the authors and all patients gave consent with the understanding that this information may be publicly available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent participant"}},{"value":"The Institutional Review Board reviewed and approved 12 the study at the Faculty of Medicine, Zagazig University (ZU-IRB#10156).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}}],"article-number":"155"}}